The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. The tenth webinar in this series features Professor Mohamad Mohty, who is the head of the Haematology and Cellular Therapy Department at the Saint-Antoine Hospital and the head of the translation research team at the Saint-Antoine Research Centre in Paris. He is the past president of the European Society for Blood and Marrow Transplantation (EBMT) and the current chairman of the Acute Leukaemia Working Party of the EBMT. He has published over 800 peer-reviewed articles in the field of stem cell transplantation, leukaemia and myeloma. In this webinar, Prof Mohty will be outlining the role of maintenance therapeutics following allogeneic HSCT for acute leukaemia.
Professor Mohamad Mohty – Saint-Antoine Hospital and Sorbonne University
When: Monday 11 October 2021, 5pm AEDT
For more information click here
Link to webinar:
Link to CBTCT website for all webinar recordings:
Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114
Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.